1. COHEN J. AIDS vaccine trial produces disappointment and confusion. Science, 299:1290-1291, 2003.
2. BURTON DR, DESROSIER RC, DOMS RW, KOFF WC, KWONG PD, MOORE JP, NABEL GJ, SODROSKI J, WILSON IA and WYATT RT. HIV vaccine design and the neutralizing antibody problem. Nature Immunology 5:233-236, 2004.
3. MALKEVITCH NV and ROBERT-GUROFF M. A call for replicating vector prime-protein boost strategies in HIV vaccine design. Expert Rev. Vaccines, 3(suppl 1):S105-S117, 2004.
4. SRIVASTAVA IK, ULMER JB and BARNETT SW. Neutralizing antibody response to HIV: role in protective immunity and challenges for vaccine design. Expert Rev. Vaccines, 3(suppl 1):S33-S52, 2004.
5. BOST KL, HAHN BH et al. Individuals infected with HIV possess antibodies against IL-2. Immunology, 65: 611-615, 1988.
6. SERRES PF. An immune response against the immune system. Role of a precise tridimensional molecular mimicry. JAI, 16: 287-291, 2001
7. GOLDING H, ROBEY FA, GATES FT, LINDER W, BEINING PR, HOFFMAN T and GOLDING B. Identification of homologous regions in human immunodeficiency virus 1 gp41 and human MHC class II beta 1 domain. Monoclonal antibodies against the gp41-derived peptides and patient's sera react with native HLA class II antigen, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med., 167(3):914-923, 1988.
8. SPEHAR T AND STRAND M. Molecular mimicry between HIV-1 gp41 and an astrocyte isoform of alpha-actinin. J. Neurovirol., 1(5-6):381-390, 1995.
9. PINTER C, SICCARDI AG, LOPALCO L, LONGHI R and CLIVIO A. HIV glycoprotein gp41 and complement factor H interact with each other and share functional as well as antigenic homology. AIDS Res. Hum. Retroviruses. 11(8):971-980, 1995.
10. CHEN YH, FENG JN, STOCKL G, HU K and DIERICH MP. HIV-1 gp41 by a common immunological epitope induces increased levels of antibodies against human interferon-beta in HIV-1 positive individuals. Mol. Immunol., 34(18):1259-1262, 1997.
11. CHEN YH, WU W, YANG J, SUL SF, SUN J and DIERICH MP. Antibodies against human IFN-alpha and beta recognized the immunosuppressive domain of HIV-1 gp41 and inhibit gp41-binding to the putative cellular receptor protein p45. Immunol. Lett., 69:253-257, 1999.
12. DOMINGUEZ V, GEVORKIAN G, GOVEZENSKY T, RODRIGUEZ H et al. Antigenic homology of HIV-1 gp41 and human platelet glycoprotein gpIIIa (integrin beta 3). J. Acquir. Immune Defic. Syndr. Hum. Retrovirol., 17(5):385-390, 1998.
13. ATTANASIO R, BRASKY KM, ROBBINS SH, JAYASHANKAR L, NASH RJ and BUTLER TM. Age-related autoantibody production in a nonhuman primate model. Clin. Exp. Immunol. 123:361-365, 2001.